EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Demystifying Nutritional Consequences of Pharmacological Weight Loss and Performance Enhancement-A Critical Narrative Review

Richa Soni, Dweipayan Goswami, Adil Gani, Prakash M Halami, Komal Chauhan

Current Obesity Reports · 12.06.2026 · 15 (1)

DOI: 10.1007/s13679-026-00729-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Obesity Reports, online erschienen am 12.06.2026. Verfasst von Richa Soni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Food Science & Nutrition, University School of Sciences, Gujarat University, Ahmedabad, 380009, Gujarat, India. richason…. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Malnutrition, Obesity, Performance-Enhancing Substances. Die Arbeit nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review This critical narrative review examines the nonmedical or aesthetic repurposing of pharmacological agents to accelerate weight loss, suppress appetite, manipulate fluid balance, and alter body composition in glamour-, fitness-, and appearance-oriented settings. The review uses the term “chemical diet” as an interpretive framework for this pattern of use and proposes “pharmacological malnutrition” as a conceptual description of drug-associated nutritional vulnerability, rather than as an established clinical diagnosis. Recent Findings Incretin-based therapies have substantial clinical value when prescribed for medically indicated obesity or metabolic disease under appropriate supervision. However, their aesthetic repurposing outside clinical governance may create nutritional and safety concerns, particularly when appetite suppression, gastrointestinal intolerance, restrictive eating, discontinuation-related weight regain, or compounded and counterfeit products are involved. Metformin is discussed mainly because of mechanistic plausibility, vitamin B12 relevance, and potential interaction with training adaptation, rather than because of strong evidence for widespread aesthetic misuse. Stimulants, β2-agonists, diuretics, thyroid hormones, anabolic-androgenic steroids, and selective androgen receptor modulators represent distinct risk categories, with hazards differing by evidence strength, severity, reversibility, and likelihood of interaction. Summary The chemical diet is best understood as an interface between pharmacology, nutrition, and public health rather than simply as off-label drug use. Its highest risk forms involve nonmedical use, pharmacological stacking, restrictive intake, dehydration practices, and uncertain supply chains. Potential consequences include gastrointestinal intolerance, impaired dietary adequacy, lean mass loss, electrolyte instability, renal stress, arrhythmogenic risk, and exposure to falsified, counterfeit, or compounded products. Greater regulatory oversight, nutrition-focused monitoring, and careful distinction between supervised therapy and unsafe aesthetic repurposing are needed. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsMalnutritionObesityPerformance-Enhancing SubstancesWeight LossHumansIncretinsMetformin

Stichwörter der Autor:innen

Anti-obesity pharmacotherapyChemical dietCounterfeit and compounded medicinesGlamour and fitness industriesIncretin-based therapiesNutritional compromiseOff-label drug usePharmacological malnutrition

Substanzen

Anti-Obesity AgentsIncretinsMetforminPerformance-Enhancing Substances

Autor:innen und Institutionen

  • Department of Life Sciences, Food Science & Nutrition, University School of Sciences, Gujarat University, Ahmedabad, 380009, Gujarat, India. richasoni@gujaratuniversity.ac.in.
  • Department of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad, 380009, Gujarat, India. dweipayan.goswami@gujaratuniversity.ac.in.
  • Department of Food Science and Technology, University of Kashmir, Srinagar, 190006, India.
  • Department of Microbiology & Fermentation Technology, CSIR- Central Food Technological Research Institute, Mysore, 570020, India.
  • Department of Foods and Nutrition, Faculty of Family & Community Sciences, The Maharaja Sayajirao University of Baroda, Vadodara, 390002, India.

Zitieren

APA

Soni, R., Goswami, D., Gani, A., Halami, P. M., & Chauhan, K. (2026). Demystifying Nutritional Consequences of Pharmacological Weight Loss and Performance Enhancement-A Critical Narrative Review. Current Obesity Reports, 15(1). https://doi.org/10.1007/s13679-026-00729-0

Vancouver

Soni R, Goswami D, Gani A, Halami PM, Chauhan K. Demystifying Nutritional Consequences of Pharmacological Weight Loss and Performance Enhancement-A Critical Narrative Review. Current Obesity Reports. 2026;15(1). doi:10.1007/s13679-026-00729-0

BibTeX
@article{Soni2026,
  author = {Soni, Richa and Goswami, Dweipayan and Gani, Adil and Halami, Prakash M and Chauhan, Komal},
  title = {Demystifying Nutritional Consequences of Pharmacological Weight Loss and Performance Enhancement-A Critical Narrative Review},
  journal = {Current Obesity Reports},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1007/s13679-026-00729-0}
}
Kostenlos starten →